CFO departure
AI Era Corp. discloses CFO departure: Dzmitry Kastahorau
AI Era Corp. reported in a Form 8-K filed June 9, 2026 a change involving its Chief Financial Officer, Dzmitry Kastahorau, effective June 3, 2026. The filing's own words are quoted below.
In the filing's words
On June 3, 2026, Dzmitry Kastahorau notified AI Era Corp. (the “Company”) of his resignation as Chief Financial Officer of the Company, effective immediately on June 3, 2026. The Company has accepted Mr. Kastahorau’s resignation.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | AI Era Corp. (AERA) |
|---|---|
| Event | Departure |
| Outgoing | Dzmitry Kastahorau |
| Effective | June 3, 2026 |
| 8-K filed | June 9, 2026 |
| SEC CIK | 0001605331 |
AI Era Corp. reported this change in a Form 8-K, Item 5.02, filed June 9, 2026. The filing's own words are quoted above.
Before and after at AI Era Corp.
The adjacent records in the company's seat timeline.
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Dzmitry Kastahorau? Send a correction with the primary source.